← FDA DRUG APPROVALS
FDA NDA · NDA021762
FOSAMAX PLUS D
alendronate sodium and cholecalciferol
Sponsor: ORGANON LLC
APPLICATION
NDA021762
TYPE
NDA
ORIGINAL APPROVAL
2005-04-07
LATEST ACTION
2026-02-03
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
FOSAMAX PLUS D · ReferencePrescription
ALENDRONATE SODIUM EQ 70MG BASE, CHOLECALCIFEROL 2,800 IU · TABLET · ORAL
FOSAMAX PLUS D · ReferencePrescription
ALENDRONATE SODIUM EQ 70MG BASE, CHOLECALCIFEROL 5,600 IU · TABLET · ORAL
Approval history
2015-07-10Manufacturing (CMC) · Supplement 19 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.